Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS
Applications
| 2021 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis
Technical notes
| 2014 | Agilent Technologies
ICP/MS, ICP/OES
Instrumentation
ICP/MS, ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Spectral Transmission Requirements for Plastic Pharmaceutical Packaging in Accordance with USP <671>
Applications
| 2023 | Agilent Technologies
UV–VIS spectrophotometry
Instrumentation
UV–VIS spectrophotometry
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validating the Agilent 7700x/7800 ICP-MS for the determination of elemental impurities in pharmaceutical ingredients according to draft USP general chapters <232>/<233>
Applications
| 2015 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Spectroscopy Solutions for Pharmaceuticals
Technical notes
| 2016 | Agilent Technologies
UV–VIS spectrophotometry
Instrumentation
UV–VIS spectrophotometry
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
ICP-MS ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS
Others
| 2017 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Measuring Elemental Impurities in Pharmaceutical Materials
Brochures and specifications
| 2022 | Agilent Technologies
Consumables, ICP/MS, ICP/OES
Instrumentation
Consumables, ICP/MS, ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Analysis of Artificial Tear Eye Drops For Elemental Impurities
Applications
| 2022 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
ICP-OES ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS
Others
| 2017 | Agilent Technologies
ICP/OES
Instrumentation
ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030